Novavax COVID vaccine is nearing approval – but what impact will it have?

novavax covid vaccine is nearing approval but what impact will it have

Sumary of Novavax COVID vaccine is nearing approval – but what impact will it have?:

  • And despite recent excitement about new drugs to treat COVID, it’s still vaccines that will underpin each country’s route out of the pandemic.
  • Vaccines can be given to large numbers of people to offer long-term protection in a way that other treatments, such as antiviral drugs, can’t.
  • Vaccines also reduce the risk of getting infected and passing the virus on.
  • Many different vaccines are now available globally, with billions of doses administered.
  • So it’s good that there are additional vaccines showing promise that could soon be widely available to boost supplies – such as Novavax’s.
  • How this vaccine works The Novavax jab is a protein subunit vaccine, and so is different from the mRNA vaccines developed by Moderna and Pfizer, the viral-vectored vaccines made by AstraZeneca and Johnson &
  • Johnson, and the inactivated-virus vaccines made by Sinovac and Sinopharm.
  • Protein subunit vaccines contain a key part of whatever it is that they protect against.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close